摘要
目的:了解鲍曼不动杆菌的临床分布特点及其耐药性。方法:对2008年-2010年间我院临床送检标本进行分离培养及鉴定,药敏试验采用K-B法。结果:2008年-2010年共检出鲍曼不动杆菌390株,临床分布以小儿ICU最多(279株,占71.5%),分离标本以痰液为主(315株,占80.8%)。对14种抗菌药物的耐药率逐年增高,12种抗菌药物的耐药率小儿ICU明显高于非ICU病区。结论:临床须重视鲍曼不动杆菌的感染,加强院内感染的控制及耐药性的监测,根据药敏结果选择合适抗生素,延缓耐药性进程。
Objective：To investigate the distribution and drug resistance of Acinetobater baumannii. Methods： Specimens from our hospital in January 2008 to December 2010 were cultured and identified. Bacteria - susceptibility test was operated by Kirby -Bauer Method. Results： 390 Acinetobacter baumanniis were isolated during three years. 279 （71.5%） of the Acinetobacter baumanniis were detected from Pediatric ICU, and 315 （80.8%） in sputum samples. The resistance rates of Acinetobacter baumannii to 14 kinds of antibiotics increased year by year and the drug resistance rates of those to 12 kinds of antibiotics from Pediatric ICU were higher than those from non ICU. Conclusion： Clinicians must value Acinetobacter baumannii infection, strengthen the control of nosocomial infection and drug resistance monitoring, select the appropriate antibiotic based on susceptibility results, delaying the process of drug resistance.
出处
《中国卫生检验杂志》
CAS
2011年第10期2551-2552,共2页
Chinese Journal of Health Laboratory Technology
关键词
鲍曼不动杆菌
抗菌药物
耐药性
Acinetobacter baumannii
Antibiotic
Drug resistance
